15 Biggest Mid-Day Gainers For Thursday - Acacia Research (NASDAQ:ACTG)

Aerie Pharmaceuticals Inc AERI shares climbed 55 percent to $32.76 on news about its Phase 3 study of Roclatan having met its primary efficacy endpoint.
Net Element International Inc NETE shares surged 41.6 percent to $1.60. Net Element shares have declined 43.50 percent over the past 52 weeks, while the S&P 500 index has gained 7.47 percent in the same period.
Caladrius Biosciences Inc CLBS gained 17.5 percent to $5.10 as the company reported a deal to raise $25 million in common equity priced at market without warrants.
CoLucid Pharmaceuticals Inc CLCD shares rose 12.3 percent to $26.10 after gaining 4.72 percent on Wednesday.
AcelRx Pharmaceuticals Inc ACRX shares gained 10.9 percent to $3.64 after the company disclosed that its investigational product candidate ARX-04 provided solid tolerance level in an open-label Phase three trial for post operative acute pain treatment.
Lakeland Industries, Inc. LAKE surged 10.3 percent to $10.35. Lakeland Industries reported Q2 earnings of $0.20 per share on revenue of $22.26 million.
bluebird bio Inc BLUE shares rose 6.7 percent to $67.08. Goldman Sachs added bluebird bio to Conviction Buy list.
Western Refining, Inc. WNR gained 5.9 percent to $27.77. JP Morgan upgraded Western Refining from Underweight to Neutral.
Teck Resources Ltd (USA) TCK rose 5.7 percent to $18.26. Morgan Stanley upgraded Teck Resources from Underweight to Equal-weight and raised the price target from $7 to $18.
Student Transportation Inc STB shares rose 4.4 percent to $5.74. Student Transportation posted stronger-than-expected results for its fourth quarter on Wednesday.
Acacia Research Corp ACTG shares gained 4.1 percent to $6.32. Acacia’s subsidiary, Cellular Communications Equipment, has won $22.1 million in patent infringement case against Apple.
Agios Pharmaceuticals Inc AGIO shares rose 3.1 percent to $46.66. Agios Pharmaceuticals priced its 3,370,786 shares offering at $44.50 per share.
Xencor Inc XNCR shares gained 3 percent to $24.06 after the company reported the initiation of Phase 1b trial of subcutaneous formulation of XmAb7195.
Global Payments Inc GPN rose 3 percent to $75.69. Goldman Sachs upgraded Global Payments from Sell to Neutral and raised the price target from $80 to $88.
Dicks Sporting Goods Inc DKS shares gained 2.5 percent to $60.09. Oppenheimer upgraded Dicks Sporting from Perform to Outperform.

Market News and Data brought to you by Benzinga APIs